Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia

Antimicrobial resistance (AMR) is a global crisis causing 8.22 million deaths annually by 2050. Asia faces the threat due to antibiotic overuse, poor health systems, and climate vulnerabilities. A strategic response involving education, prevention, monitoring, and long-term marathons could save $55 billion annually by the next decade. This paper encourages private funders, impact investors, and philanthropists to support the fight.